← All indications
Necrosis
The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
Subtype terms (6)
More specific conditions that are subtypes of Necrosis in the MeSH hierarchy.
- Dental Pulp Necrosis
21 drugs (11 approved, 10 experimental)
- DNA Degradation, Necrotic
- Fat Necrosis
- Gangrene
3 drugs experimental
- Infarction
4 drugs (3 approved, 1 experimental)
- Osteonecrosis
25 drugs (12 approved, 13 experimental)
Drugs by status
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (31)
- Amgen
- Novartis
- R-Pharm
- Fondazione Mediolanum per Attività e Ricerche Cardiovascolari Onlus
- National Cancer Institute (NCI)
- University of Roma La Sapienza
- Shahid Beheshti University of Medical Sciences
- University of Washington
- Hoosier Cancer Research Network
- Instituto Venezolano de Investigaciones Cientificas
- Oregon Health and Science University
- Phoenix Molecular Imaging
- Postgraduate Institute of Medical Education and Research
- Seoul National University
- University of Lausanne
- University of Michigan
- University of Tehran
- Jiao Tong University
- Louisiana State University
- Al Azhar University
- Janssen Pharmaceutica NV
- University of Alabama, Birmingham
- American College of Surgeons
- URC Paris Centre
- OCT Clinical Trials
- MENE Research
- New York Center for Orthognathic and Maxillofacial Surgery
- Sanya People's Hospital
- Ghent University
- IQVIA
- +1 more
Organization Involved with Phase 2 Indications (39)
- Bristol-Myers Squibb
- Gilead Sciences
- MedImmune
- Sanofi
- Immodulon Therapeutics Ltd
- MolMed S.p.A.
- Bone Therapeutics S.A
- The Foundation Institute San Raffaele G. Giglio of Cefalù
- National Institutes of Health (NIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Alexandria University
- Azad University
- Banc de Sang i Teixits
- Chung Shan Medical University
- Federal University of Bahia
- Guangzhou Medical University
- Indiana University
- New York University
- Norton Healthcare
- Universidad Autonoma de Madrid
- University of Kentucky
- University of Nebraska
- University of Bergen
- Zagazig University
- University of California, Irvine
- University of California, San Francisco
- University of Cincinnati
- Leaders In Oncology Care, Harley St, London
- Federal University of Piaui
- +9 more
Organization Involved with Phase 1 Indications (17)
- AlloCure Inc.
- Hoechst Marion Roussel
- Innovent Biologics (Suzhou) Co. Ltd.
- Central South University
- Allegiance Health
- Case Western Reserve University
- University of London
- Emory University
- Loma Linda University
- University of Maryland
- Yale University
- Tsinghua University
- University of North Carolina at Chapel Hill
- University of Texas, San Antonio
- American Association of Endodontists
- The Cleveland Clinic
- The University of Texas, Dallas
Organization Involved with Other Experimental Indications (17)
- Actelion
- Immunex
- Genentech
- Healthpoint
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Katholieke Universiteit Leuven
- Stanford University
- University of Toronto
- University of British Columbia
- University of Colorado, Denver
- University of Freiburg
- Umea University
- Southern Medical University
- University of Lille
- Karolinska Institute
- University of Wisconsin
- University of Colorado